Based on the bioinformatics analyses and experimental verification presented in this study, we concluded from these results that anti-POSTN and anti-TIMP1 autoantibodies could be considered potential diagnostic markers for ESCC. The gene discussed is POSTN; the disease is esophageal squamous cell carcinoma.